AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT PR Newswire EMERYVILLE, Calif., April 14, 2022 EMERYVILLE, Calif...
AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT PR Newswire EMERYVILLE, Calif., April 11...
Table of Contents PRELIMINARY PROXY STATEMENTSUBJECT TO COMPLETION ...
VegTech™ Invest Launches the VegTech™ Plant-based Innovation & Alternative Proteins Index PR Newswire LOS...
NASDAQ false 0001365916 0001365916 2022-03-23 2022-03-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
Table of Contents Filed Pursuant to Rule 424(b)(7) Registration No. 333-255105 PROSPECTUS SUPPLEMENT...
AMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEK PR Newswire EMERYVILLE, Calif., March 17, 2022 EMERYVILLE, Calif., March...
AMYRIS CLOSES ACQUISITION OF MENOLABS PR Newswire EMERYVILLE, Calif., March 11, 2022 EMERYVILLE, Calif., March...
H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Amyris (AMRS – Research Report) today and set a price target of $22.00. The...
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS - 2021 full year total revenue grew...
AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE PR Newswire EMERYVILLE, Calif., Feb. 28, 2022 EMERYVILLE, Calif., Feb. 28, 2022...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC ...
AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1 PR Newswire EMERYVILLE, Calif., Feb. 22, 2022...
FORM 5 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). [ ] Form 3...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.